APP and early-onset autosomal dominant Alzheimer disease: β-amyloid is a product of APP that is also associated with a decrease in established Alzheimer’s disease [25]; however, it is not clear what plasma APP levels are found in those at risk of developing Alzheimer’s disease and whether an elevation may precede the subsequent decrease in established disease.